Detailed analysis metrics
Metric | Description |
|---|---|
Sample ID | Name of the sequenced sample imported from a sequencing run. |
SNV/INDEL | |
Gene | HGNC reviewed official gene symbol. |
AA Chg | Amino acid change resulting from non-synonymous DNA variant. |
Mutant Frequency % | Frequency of mutant allele expressed as a percentage. |
Oncomine Variant Class | Variant class annotation that provides a high-level summary of the variant type (hotspot, fusion, amplification, and so on). The annotation is included when the Oncomine™ Variant Annotator plugin is run in Ion Reporter™ Software. |
Oncomine Gene Class | Variant gene functional annotation that provides a high-level summary of gene type (Gain-of-Function, Loss-of-Function, or Unclassified). The annotation is included when the Oncomine™ Variant Annotator plugin is run in Ion Reporter™ Software. |
Info | HS (targeted hotspot) or PN (potentially novel TP53 variant). De novo variant calls available for the breast panel only. |
Genotype | Genotype measured associated with a DNA variant call. |
Ref Allele | Reference allele as defined in the human genome reference (hg19). |
Mut Molecular Cov. | Molecular coverage of the mutant allele. |
WT Molecular Cov. | Molecular coverage of the wild type allele from the reference genome. |
Depth | Total read coverage across amplicon containing SNV/INDEL hotspot locations. Count of chip-level reads aligned at this locus that participate in variant calling. Note: This description applies to both, Ion AmpliSeq™ HD and non‑Ion AmpliSeq™ HD analyses. |
QC Test (LOD) % | Quality control check for SNV/INDEL target regions based on molecular coverage. |
Transcript ID | NCBI accession number for the transcript representing the gene target being measured. |
Locus | Chromosome and position of detected variant. Click the hyperlink to open the Ion Reporter™ Genomic Viewer to the specified locus. |
CNV | |
Gene | Gene locus targeted for CNV measurement. |
Gain/Loss | Detected copy number gain or loss. |
CNV ratio | Ratio of measured CNV gene locus coverage relative to coverage on non-CNV loci. |
p-value | Significance of CNV ratio measurement. |
Med. Mol Cov. Gene | Median molecular coverage of targeted CNV gene. |
Med. Mol Cov. Ref | Median molecular coverage of non-CNV reference loci. |
Med. Read Cov. Gene | Median read coverage of targeted CNV gene. |
Med. Read Cov. Ref | Median read coverage of non-CNV reference loci. |
QC Test | Assay quality control as determined by amplicon coverage uniformity and number of amplicons remaining after outlier removal. |
Valid CNV Amplicons | Number of CNV amplicons remaining after outlier removal. |
CNV Locus | Chromosomal location of CNV gene being targeted. |
Fusion | |
Variant (exons) | Name of fusion targeted and respective acceptor and donor exons. |
Oncomine Driver Gene | The gene thought to be associated with increased oncogenic properties due to inappropriate activation by the fusion. |
COSMIC/NCBI | COSMIC mutation or NCBI accession number. |
Mol Cov. Mutant | Median molecular coverage across fusion amplicon. |
Read Cov. Mutant | Median read coverage across fusion amplicon. |
Detection | Detection status from assay. |
QC Test | Assay quality control measured from expression detection of housekeeping genes. |
Type | Assay type (For example, Fusion, RNA exon variant (exon skipping), Proc Control). |
Locus | Chromosomal locations of targets included in assay. |
Ratio To Wild Type | Ratio molecular for exon skipping assay relative to wild type control amplicons. |
Norm count Within Gene | Exon skipping assay coverage normalized to molecular coverage of wild type (WT) MET control amplicons. (Lung panel only). |
